ClinConnect ClinConnect Logo
Search / Trial NCT03509714

Oxaloacetate Supplementation for Emotional PMS

Launched by TERRA BIOLOGICAL LLC · Apr 20, 2018

Trial Information

Current as of July 23, 2025

Completed

Keywords

ClinConnect Summary

Oxaloacetate is an energy metabolite found in every cell of the human body. It holds a key place in the Krebs Cycle within the mitochondria, providing energy to the cells. It is also a critical early metabolite in gluconeogenesis, which provides glucose for the heart and brain during times of low glucose. It is critical to human metabolism, proper cellular function and it is central to energy production and use in the body.

Oxaloacetate may affect Emotional PMS through multiple mechanisms. During PMS, there is a large increase in glucose utilization in the cerebellum of the brain in women ...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women with Emotional Premenstrual Syndrome (PMS),
  • Women who speak English as their primary language
  • Women who understand the Human Consent Form
  • Ability to swallow capsules
  • Exclusion Criteria:
  • Formal diagnosis of clinical depression
  • Formal diagnosis of premenstrual dysphoric disorder (PMDD).

About Terra Biological Llc

Terra Biological LLC is a pioneering clinical trial sponsor dedicated to advancing innovative therapeutic solutions in the life sciences sector. With a focus on developing cutting-edge treatments, the company leverages a robust research framework and a team of experienced professionals to conduct rigorous clinical trials. Terra Biological LLC is committed to maintaining the highest standards of scientific integrity and regulatory compliance, ensuring that its studies contribute valuable insights to the medical community and enhance patient care. Through strategic partnerships and a patient-centric approach, Terra Biological LLC strives to address unmet medical needs and foster breakthroughs in drug development.

Locations

Patients applied

0 patients applied

Trial Officials

Lisa Tully, PhD

Study Director

Energy Medicine research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials